All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BIOSPLICE THERAPEUTICS, INC. · Pharmaceutical company.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$110,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

MOLLY BRIMMER-LOLLI New on this filing

Previously held: Sr Cnsl, H Energy&Commrce Comm, Health Subcomm (2025-26); Cnsl H Energy&Commrce Comm, Health Subcomm (2023-25); Leg Dir, Rep. Hudson (2022-23); Sr Health Policy Advsr Rep. Hudson (2021-22); Leg Asst, Rep. Harris (2019-2021); Intrn, Rep. Harris (2014)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

Executive Office of the President (EOP)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Lobbying activity 1

Health Issues

Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.